Post allo-HSCT (allogeneic hematopoietic stem cell transplantation), CD4IL10 cells would inhibit graft vs host disease (GvHD) via secretion of IL-10, while boosting graft vs leukemia (GvL). The gene discussed is IL10; the disease is leukemia.